🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 19 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
01/08/2011 8,94 9,24 8,64 8,64 -2,04% 6,71% 95.867
29/07/2011 8,76 8,94 8,40 8,82 +0,00% 6,16% 95.083
28/07/2011 8,82 9,30 8,64 8,82 +0,68% 7,48% 110.483
27/07/2011 9,30 9,72 8,70 8,76 -6,41% 10,97% 203.667
26/07/2011 9,72 9,96 9,36 9,36 -3,70% 6,17% 77.850
25/07/2011 9,78 9,96 9,42 9,72 +1,25% 5,52% 157.783
22/07/2011 9,84 9,84 9,60 9,60 -2,44% 2,44% 135.900
21/07/2011 9,84 10,08 9,66 9,84 +1,23% 4,27% 169.550
20/07/2011 9,60 10,08 9,48 9,72 -1,22% 6,25% 191.850
19/07/2011 9,60 9,84 9,36 9,84 +3,80% 5,00% 184.267
18/07/2011 9,54 9,66 9,36 9,48 -1,86% 3,14% 111.617
15/07/2011 9,72 9,78 9,60 9,66 -0,62% 1,85% 84.517
14/07/2011 9,78 9,90 9,60 9,72 -0,61% 3,07% 75.217
13/07/2011 9,60 9,96 9,54 9,78 +2,52% 4,38% 111.083
12/07/2011 9,66 9,84 9,30 9,54 -1,85% 5,59% 180.900
11/07/2011 9,78 10,08 9,30 9,72 -1,82% 7,98% 142.917
08/07/2011 9,66 10,20 9,30 9,90 +0,61% 9,32% 195.317
07/07/2011 9,66 9,96 9,60 9,84 +1,23% 3,73% 174.767
06/07/2011 8,94 9,90 8,88 9,72 +8,72% 11,41% 312.267
05/07/2011 8,70 8,94 8,58 8,94 +2,05% 4,14% 118.350
01/07/2011 8,64 8,82 8,58 8,76 +2,10% 2,78% 83.667
30/06/2011 8,64 8,82 8,58 8,58 -0,69% 2,78% 99.967
29/06/2011 8,70 8,94 8,58 8,64 -0,69% 4,14% 135.500
28/06/2011 8,34 8,82 8,28 8,70 +4,32% 6,47% 187.833
27/06/2011 8,40 8,40 8,16 8,34 -0,71% 2,86% 113.267
24/06/2011 8,28 8,40 8,10 8,40 +2,94% 3,62% 221.067
23/06/2011 8,28 8,28 8,10 8,16 -1,45% 2,17% 153.967
22/06/2011 8,46 8,64 8,28 8,28 -2,13% 4,26% 144.183
21/06/2011 8,16 8,46 8,16 8,46 +2,17% 3,68% 128.433
20/06/2011 8,34 8,46 8,10 8,28 -0,72% 4,32% 111.233